U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07313670) titled 'Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock' on Dec. 10, 2025.
Brief Summary: Although, hydrocortisone has shown promise in managing refractory shock, its role in early septic shock management remains unclear. This study aims to provide robust evidence on the clinical and hemodynamic outcomes of early hydrocortisone use in pediatric septic shock, contributing to standardized treatment protocols and improved survival rates.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Septic Shock
Intervention:
DRUG: Intravenous Hydrocortisone
Children will receive early intravenous hydrocorti...